Publications by authors named "Shingo YANO"

Claim this Profile
L
Light chain proximal tubulopathy in Sjögren syndrome: the critical role of tubular function tests in revealing a hidden threat.
Haruki Mae, Go Kanzaki, Yumeka Inamura, Nanae Matsuo, Shiko Honma, Shingo Yano

CEN Case Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.
Takayuki Fujii, Masatoshi Sakurai, Hiroaki Shimizu, Akihiko Izumi, Kenji Kimura, Shingo Yano

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation.
Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada, Takuya Miyazaki, Shingo Yano

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.
Yuma Noguchi, Takehiko Mori, Yasushi Onishi, Yukinori Nakamura, Minoru Kanaya, Shingo Yano

Int J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successfully maintained complete remission of mycosis fungoides by umbilical cord blood transplantation: a case report and literature review.
Munenari Itoh, Sayaka Oshima, Hiroto Ishii, Shingo Yano, Akihiko Asahina

Dermatol Reports· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Methadone for Refractory Cancer Pain, Including Add-On Switching to Prior Opioids.
Yuko Shiota, Kyoko Ueda, Yuta Miyazawa, Shono Kikuta, Nami Suda, Shingo Yano

Gan To Kagaku Ryoho· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Onco-cardiology in hematopoietic malignancies].
Shingo Yano

Rinsho Ketsueki· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.
Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin-Ichiro Fujiwara, Yuho Najima, Shingo Yano

Hematol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Area under tacrolimus concentrations predict outcomes after unrelated allogeneic hematopoietic stem cell transplantation.
Susumu Tanoue, Takeshi Saito, Hiroki Yokoyama, Hiroto Ishii, Aya Ouchi-Nakano, Shingo Yano

Int J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Depth of the Treatment Response Before Allogeneic Hematopoietic Transplantation for Chronic Myeloid Leukemia in Chronic Phase.
Yosuke Okada, Takeshi Kondo, Takuya Miyazaki, Yutaka Shimazu, Yosuke Minami, Shingo Yano

Am J Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.
Kazuhito Suzuki, Tadahiro Gunji, Riku Nagao, Masaharu Kawashima, Hideki Uryu, Shingo Yano

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation.
Shoko Ishii, Yasuhiro Arakawa, Hiroto Ishii, Kazuaki Yokoyama, Hiroki Yokoyama, Shingo Yano

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimens.
Takuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, Shingo Yano, Yoshimitsu Shimomura

Bone Marrow Transplant· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.
Yasuyuki Arai, Ruta Brazauskas, Naya He, A Samer Al-Homsi, Saurabh Chhabra, Shingo Yano

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.
Shinichiro Oshima, Yasuyuki Arai, Tadakazu Kondo, Shingo Yano, Shigeki Hirabayashi

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns.
Mizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, Shoichi Fukui, Yuko Kaneko, Shingo Yano

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.
Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa, Yukinori Ozaki, Hiroshi Nishio, Shingo Yano

Int J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual compartment utility of BRET-based biosensors for PPP2R5A/B56α, a cancer-associated B regulatory subunit of PP2A.
Hirofumi Yamauchi, Atsuro Oishi, Masahiko Ajiro, Atsuhito Nakayama, Kazuki Nishimura, Shingo Yano

Biotechniques· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission.
Yoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, Shohei Mizuno, Tadakazu Kondo, Shingo Yano

Cytotherapy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease.
Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita, Hiroshi Yano, Shingo Yano

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib.
Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita, Hiroshi Yano, Shingo Yano

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.
Kazuhito Suzuki, Riku Nagao, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Shingo Yano

Int J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.
Kazuhito Suzuki, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Riku Nagao, Shingo Yano

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.
Kazuhito Suzuki, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Riku Nagao, Shingo Yano

Cancer Diagn Progn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey.
Machi Suka, Atsushi Katsube, Reiko Fujimoto, Tadashi Uwagawa, Takashi Shimada, Shingo Yano

Support Care Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis